当前位置:首页 - 行情中心 - 三诺生物(300298) - 财务分析 - 现金流量表

三诺生物

(300298)

  

流通市值:89.94亿  总市值:111.66亿
流通股本:4.51亿   总股本:5.60亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,314,897,963.051,176,327,131.634,352,894,977.113,181,478,797.82
  收到的税费返还32,707,979.7831,872,657.5684,453,205.5460,138,521.59
  收到其他与经营活动有关的现金30,888,700.9812,876,595.7956,637,208.0418,877,368.67
  经营活动现金流入小计2,378,494,643.811,221,076,384.984,493,985,390.693,260,494,688.08
  购买商品、接受劳务支付的现金831,951,659.65397,118,598.291,574,703,161.621,160,869,008.27
  支付给职工以及为职工支付的现金630,306,905.15313,436,706.111,084,582,640.49827,353,070.99
  支付的各项税费148,759,718.982,091,472.56281,150,922.96190,424,401.89
  支付其他与经营活动有关的现金494,111,528.48231,350,988.14922,259,766.45678,682,001.61
  经营活动现金流出小计2,105,129,812.181,023,997,765.13,862,696,491.522,857,328,482.76
  经营活动产生的现金流量净额273,364,831.63197,078,619.88631,288,899.17403,166,205.32
二、投资活动产生的现金流量:
  收回投资收到的现金24,116,726.2124,116,726.2185,683,300265,683,300
  取得投资收益收到的现金831,286.13575,874.591,135,959.66727,531.17
  处置固定资产、无形资产和其他长期资产收回的现金净额15,285.957,565.6635,053.57103,749
  收到的其他与投资活动有关的现金545,843,936.97289,463,874.19404,198,233.36861,818.18
  投资活动现金流入小计570,807,235.26314,164,040.59491,652,546.59267,376,398.35
  购建固定资产、无形资产和其他长期资产支付的现金127,379,358.1349,873,378.86186,668,722.05166,036,824.52
  投资支付的现金---200,000,000
  支付其他与投资活动有关的现金494,101,866.61219,472,650.34480,000,000-
  投资活动现金流出小计621,481,224.74269,346,029.2666,668,722.05366,036,824.52
  投资活动产生的现金流量净额-50,673,989.4844,818,011.39-175,016,175.46-98,660,426.17
三、筹资活动产生的现金流量:
  取得借款收到的现金149,435,572.6595,764,138.73154,444,750.0294,488,083.34
  收到其他与筹资活动有关的现金--77,070,000-
  筹资活动现金流入小计149,435,572.6595,764,138.73231,514,750.0294,488,083.34
  偿还债务支付的现金252,000,000245,000,000413,966,000187,816,000
  分配股利、利润或偿付利息支付的现金123,146,682.61900,836.8132,189,521.63122,208,054.51
  支付其他与筹资活动有关的现金88,769,928.824,385,526.669,632,746.3963,750,573.24
  筹资活动现金流出小计463,916,611.43250,286,363.4615,788,268.02373,774,627.75
  筹资活动产生的现金流量净额-314,481,038.78-154,522,224.67-384,273,518-279,286,544.41
四、汇率变动对现金及现金等价物的影响1,870,204.87577,999.3-9,210,729.26-13,889,201.94
五、现金及现金等价物净增加额-89,919,991.7687,952,405.962,788,476.4511,330,032.8
  加:期初现金及现金等价物余额842,454,892.22841,462,707.35779,666,415.77779,666,415.77
  期末现金及现金等价物余额752,534,900.46929,415,113.25842,454,892.22790,996,448.57
补充资料:
  净利润182,071,127.84-345,854,598.97-
  资产减值准备-3,859,586.47-74,396,452.82-
  固定资产和投资性房地产折旧68,589,588.51-149,914,792.45-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧68,589,588.51-149,914,792.45-
  无形资产摊销20,809,759.48-50,474,766.9-
  长期待摊费用摊销2,599,615.03-5,535,090.2-
  处置固定资产、无形资产和其他长期资产的损失325,746.84--957,336.24-
  财务费用18,799,668.78-48,132,581.04-
  投资损失-825,810.72-1,595,366.95-
  递延所得税47,192.6--4,497,711.4-
  其中:递延所得税资产减少-299,478.65--1,490,560.18-
    递延所得税负债增加346,671.25--3,007,151.22-
  存货的减少-45,761,721.73--34,161,589.23-
  经营性应收项目的减少-75,065,319.29--156,399,233.44-
  经营性应付项目的增加97,999,960.35-107,870,131.92-
  现金的期末余额752,534,900.46-842,454,892.22-
  减:现金的期初余额842,454,892.22-779,666,415.77-
  现金及现金等价物的净增加额-89,919,991.76-62,788,476.45-
公告日期2025-08-282025-04-292025-04-212024-10-24
审计意见(境内)标准无保留意见
TOP↑